document.write(`

   <li>Functional and molecular profiling of hematopoietic stem cells during regeneration. Rydström A, Grahn THM, Niroula A, et al. Exp Hematol (2023). <a href="https://doi.org/10.1016/j.exphem.2023.08.010">doi.org/10.1016/j.exphem.2023.08.010</a></li><br>

   <li>Genetic modification of inflammation-and clonal hematopoiesis–associated cardiovascular risk. Yu Z, Fidler TP, Ruan Y, et al. J Clin Invest (2023). <a href="https://doi.org/10.1172/JCI168597">doi.org/10.1172/JCI168597</a></li><br>

   <li>Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood. Schuermans A, Nakao T, Ruan Y, et al. J Am Heart Assoc (2023). <a href="https://doi.org/10.1161/JAHA.123.030220">doi.org/10.1161/JAHA.123.030220</a></li><br>

   <li>Obesity-induced inflammation exacerbates clonal hematopoiesis. Pasupuleti SK, Ramdas B, Burns SS, et al. J Clin Invest (2023). <a href="https://doi.org/10.1172/JCI163968">doi.org/10.1172/JCI163968</a></li><br>

   <li>Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease. Gumuser ED, Schuermans A, Cho SMJ, et al. J Am Coll Cardiol (2023). <a href="https://doi.org/10.1016/j.jacc.2023.03.401">doi.org/10.1016/j.jacc.2023.03.401</a></li><br>

   <li>A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets. Vlasschaert C, Mack T, Heimlich JB, et al. Blood (2023). <a href="https://doi.org/10.1182/blood.2022018825">doi.org/10.1182/blood.2022018825</a></li><br>

   <li>Prediction of risk for myeloid malignancy in clonal hematopoiesis. Weeks LD, Niroula A, Neuberg D, et al. NEJM Evid (2023). <a href="https://doi.org/10.1056/evidoa2200310">doi.org/10.1056/evidoa2200310</a></li><br>

   <li>Clonal haematopoiesis and risk of chronic liver disease. Wong WJ, Emdin C, Bick AG, et al. Nature (2023). <a href="https://doi.org/10.1038/s41586-023-05857-4">doi.org/10.1038/s41586-023-05857-4</a></li><br>

   <li>HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia. Narayan R, Niroula A, Wang T, et al. Transplant Cell Ther (2023). <a href="https://doi.org/10.1016/j.jtct.2023.03.027">10.1016/j.jtct.2023.03.027</a></li><br>
                              
   <li>Clonal hematopoiesis and risk of incident lung cancer. Tian R, Wiley B, Liu J, et al. J Clin Oncol (2023). <a href="https://doi.org/10.1200/JCO.22.00857">doi.org/10.1200/JCO.22.00857</a></li><br>

   <li>TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Zekavat SM, Viana-Huete V, Matesanz N, et al. Nat Cardiovasc Res (2023). <a href="https://10.1038/s44161-022-00206-6">doi.org/10.1038/s44161-022-00206-6</a></li><br>

`);
